FDA Commissioner Resignation: Marty Makary Steps Down Amid Backlash

AI Summary

Dr. Marty Makary resigned as FDA commissioner, a role he held for over a year, amidst criticism from the White House and industry stakeholders. President Donald Trump announced that Kyle Diamantas will serve as the acting commissioner. The resignation follows reports of growing impatience from the administration regarding Makary's performance on key initiatives, including the regulation of flavored vapes and the abortion pill mifepristone. The FDA's aggressive drug approval pace, which Makary promoted, will now face scrutiny from his successor against a backdrop of recent high-profile treatment rejections.